significant drug interaction (P769)

From Mepdata
Revision as of 09:44, 11 November 2022 by imported>Pallor (‎Created claim: Wikidata property example (P1855): Q416978)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
clinically significant interaction between two pharmacologically active substances (i.e., drugs and/or active metabolites) where concomitant intake can lead to altered effectiveness or adverse drug events.
  • drug interaction
  • pharmacological interaction
Language Label Description Also known as
English
significant drug interaction
clinically significant interaction between two pharmacologically active substances (i.e., drugs and/or active metabolites) where concomitant intake can lead to altered effectiveness or adverse drug events.
  • drug interaction
  • pharmacological interaction

Data type

Item

Statements

instance of
Q19887775 (Deleted Item)
0 references
Wikidata item of this property
Q718753 (Deleted Item)
0 references
Wikidata property example
Q407431 (Deleted Item)
significant drug interaction
Q417740 (Deleted Item)
0 references
Q416978 (Deleted Item)
significant drug interaction
Q409595 (Deleted Item)
Q1747559 (Deleted Item)
Q420885 (Deleted Item)
0 references
property usage tracking category
Q26249998 (Deleted Item)
0 references
property constraint
Q21503250 (Deleted Item)
class
Q12140 (Deleted Item)
relation
Q30208840 (Deleted Item)
0 references
Q21503247 (Deleted Item)
property
DrugBank ID
0 references
Q21510865 (Deleted Item)
class
Q12140 (Deleted Item)
relation
Q30208840 (Deleted Item)
0 references
Q21510864 (Deleted Item)
property
DrugBank ID
0 references
Q53869507 (Deleted Item)
constraint status
Q21502408 (Deleted Item)
property scope
Q54828448 (Deleted Item)
0 references
Retrieved from "https://mepdata.org/index.php?title=Property:P769&oldid=10732"